Summary:
What is the STARS study?
The STARS clinical research study is evaluating whether an investigational medication called sarizotan is safe and effective in reducing the number of daytime apnea and other breathing episodes in people who have Rett syndrome with irregular breathing.
Who can participate?
A person with Rett syndrome may be able to join the STARS study if he or she:
- Is at least 6 years old
- Weighs at least 22 pounds or 10 kilograms
- Has episodes of irregular breathing while awake during the day
- Meets other study participation requirements that the study staff will discuss with you
All potential study participants will have their breathing evaluated at home using a device that will count their irregular breathing episodes. This evaluation will determine whether the severity of their symptoms meet the study requirements.
Before choosing to participate in a clinical research study you can speak to your doctor to find out more information about clinical research.